Biotech

All Articles

Otsuka pays for $800M for Jnana as well as its clinical-stage PKU medication

.Otsuka Pharmaceutical has actually grabbed Boston-based Jnana Therapeutics for $800 thousand so the...

FibroGen gives up 75% of US workers as asset flunks 2 even more trials

.FibroGen is actually drastically reorganizing its own business, laying off 75% of its USA personnel...

Tracon wane weeks after injectable PD-L1 inhibitor fail

.Tracon Pharmaceuticals has actually made a decision to relax operations weeks after an injectable i...

Ideaya bags alternative on Biocytogen bispecific ADC in $400M bargain

.Ideaya Biosciences is actually betting $400 thousand in biobucks that a bispecific antibody-drug co...

Takeda takes $140M loss on neglected epilepsy medication, promotes FDA manage

.Our team currently recognize that Takeda is planning to locate a course to the FDA for epilepsy med...

VBI Vaccines apply for insolvency, looks for possession sale

.Immunology biotech VBI Vaccinations is drifting hazardously near to the point of no return, with pl...

Celldex anti-cKIT antitoxin lessen hives in an additional stage 2 study

.It's hard to muscle in on a room as reasonable as immunology, yet Celldex Therapeutics strongly bel...

Boehringer offers up to $1.3 B for checkpoint prevention biotech

.Boehringer Ingelheim is actually offering up to $1.3 billion for Nerio Therapies as well as a precl...

Ventyx's last hope for inflammatory med ends in Crohn's failure

.Ventyx Biosciences' Crohn's illness medicine did certainly not help clients achieve remission in a ...

Cognition's period 2 SHINE data stain Alzheimer's prospect

.Knowledge Therapeutics' period 2 luster test has actually taken a few of the gloss off the Alzheime...